Drugs Made In Amer Acq Ii Stock Price, News & Analysis
Company Description
Drugs Made In Amer Acq Ii (NASDAQ: DMII) is a publicly traded shell companies company in the Blank Checks sector. The company has a market capitalization of $655.1M, ranking #3,231 among all listed U.S. companies by market cap.
DMII stock has gained 1.1% over the past year, placing it at #2,166 in year-to-date performance among tracked companies. Shares last traded at $9.99.
This page provides a comprehensive overview of DMII stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Drugs Made In Amer Acq Ii (DMII) stock last traded at $9.99. Over the past 12 months, the stock has gained 1.1%. At a market capitalization of $655.1M, DMII is classified as a small-cap stock with approximately 65.6M shares outstanding.
Latest News
SEC Filings
Drugs Made In Amer Acq Ii has filed 5 recent SEC filings, including 4 Form 8-K, 1 Form NT 10-K. The most recent filing was submitted on April 3, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all DMII SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Drugs Made In Amer Acq Ii (DMII) currently stands at 57.9 thousand shares, down 25.5% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has increased by 29.5%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Drugs Made In Amer Acq Ii (DMII) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 8.8 days.
DMII Company Profile & Sector Positioning
Drugs Made In Amer Acq Ii (DMII) operates in the Shell Companies industry within the broader Blank Checks sector and is listed on the NASDAQ. In monthly performance, the stock ranks #3,195 among all tracked companies.